查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1620668

亞磷醯胺市場：按類型、純度等級、最終用戶、應用分類 - 全球預測 2025-2030

Phosphoramidite Market by Type (DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites), Purity Level (High Purity, Standard Purity), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年亞磷醯胺市值為12億美元，預計2024年將達12.8億美元，複合年成長率為7.29%，預計到2030年將達到19.7億美元。

亞磷醯胺是寡核苷酸合成中使用的主要試劑。寡核苷酸是短核酸鏈，對於基因檢測、治療和研究等多種應用至關重要。它的需求源於它在促進 DNA 和 RNA 化學合成方面的作用，這對於生物製藥和基因療法的開發至關重要。最終用途包括製藥公司、生技公司和學術研究機構。市場洞察表明，對個人化醫療的需求不斷成長以及基因組和分子診斷應用的不斷擴大是關鍵的成長動力。此外，合成生物學研究投資的增加以及 CRISPR 等基因編輯技術的進步正在創造重大商機。為了利用這些發展，公司可以專注於提高亞磷醯胺的產品純度、保存期限和成本效益。

主要市場統計
基準年[2023] 12億美元
預測年份 [2024] 12.8億美元
預測年份 [2030] 19.7億美元
複合年成長率（%） 7.29%

然而，市場面臨挑戰，主要是與亞磷醯胺合成相關的高成本以及需要嚴格的儲存條件來維持反應性。監管障礙和品管問題也對市場擴張構成挑戰。此外，核酸療法發展迅速，需要不斷創新並需要在研發方面進行大量投資。需要創新的領域包括開發環保合成方法和自動化製造程序，以提高可擴展性並降低成本。探索生產更有效和穩定的亞磷醯胺類似物的合成路線也將是有益的。

對於尋求發展的公司來說，對合成過程和監管環境的技術理解是關鍵。與研究機構和生物技術公司建立合作以加速寡核苷酸療法的進步可以提供競爭優勢。以快速技術轉變和應用演進為特徵的動態市場特徵強調了敏捷性和適應性的重要性。認知到這些因素並對技術進步進行策略性投資可以幫助公司在現有市場限制和挑戰的情況下成功抓住新機會。

市場動態：揭示快速發展的亞磷醯胺市場的關鍵市場洞察

供需的動態交互作用正在改變亞磷醯胺市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 研究和治療應用對 DNA 和 RNA 寡核苷酸的需求不斷增加
    • 使用寡核苷酸合成的個人化醫療解決方案的需求快速成長
    • 製藥和生物技術產業的擴張
  • 市場限制因素
    • 亞磷醯胺合成中的高成本和擴充性問題
  • 市場機會
    • 政府對生物技術研究的資助激增
    • 生物技術和製藥公司之間的持續合作和夥伴關係
  • 市場挑戰
    • 與亞磷醯胺合成相關的環境與安全問題

波特五力：駕馭亞磷醯胺市場的策略工具

波特的五力框架是了解亞磷醯胺市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解對亞磷醯胺市場的外部影響

外部宏觀環境因素在塑造亞磷醯胺市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解亞磷醯胺市場的競爭格局

對亞磷醯胺市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣亞磷醯胺市場供應商績效評估

FPNV定位矩陣是評估亞磷醯胺市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了亞磷醯胺市場的成功之路

亞磷醯胺市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 研究和治療應用對 DNA 和 RNA 寡核苷酸的需求增加
      • 使用寡核苷酸合成的個人化醫療解決方案的需求迅速成長
      • 製藥和生物技術產業的擴張
    • 抑制因素
      • 亞磷醯胺合成的高成本和可擴展性問題
    • 機會
      • 政府對生物技術研究的資助激增
      • 生物技術和製藥公司之間的持續合作和夥伴關係
    • 任務
      • 與亞磷醯胺合成相關的環境與安全問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章亞磷醯胺市場：依類型

  • DNA亞磷醯胺
  • 染料標記的亞磷醯胺
  • RNA亞磷醯胺
  • 特殊亞磷醯胺

第7章依純度等級分類的亞磷醯胺市場

  • 高純度
  • 標準純度

第8章亞磷醯胺市場：依最終用戶分類

  • 學術/研究機構
  • 合約調查機構
  • 診斷實驗室
  • 製藥/生物技術

第9章亞磷醯胺市場：依應用分類

  • 診斷開發
  • 藥物發現與開發

第10章美洲亞磷醯胺市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區亞磷醯胺市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲亞磷醯胺市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Codexis 徹底改變了酶促 RNA 合成技術，提高了效率和擴充性
    • Innovassynth 和 Actylis 合作解決核酸供應鏈中的漏洞
  • 戰略分析和建議
    • 賽默飛世爾科技有限公司

公司名單

  • AAT Bioquest, Inc.
  • Actylis
  • Amadis Chemical Company Limited
  • American International Chemical, LLC by LeBaronBrown Industries LLC
  • Beijing SBS Genetech Co., Ltd.
  • Bioneer Corporation
  • Biosynth Ltd.
  • BOCSCI Inc.
  • ChemGenes Corporation
  • Creative Biolabs, Inc.
  • Hongene Biotech Corporation
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • LGC Genomics Limited
  • Lumiprobe Corporation
  • Maravai LifeSciences Holdings, Inc.,
  • MedChemExpress
  • Merck KGaA
  • PolyOrg, Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Twist Bioscience Corporation
  • Wuhu Huaren Science and Technology Co., Ltd.
Product Code: MRR-EA74537D7BA2

The Phosphoramidite Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 7.29%, to USD 1.97 billion by 2030.

Phosphoramidites are key reagents used in the synthesis of oligonucleotides, which are short strands of nucleic acids vital for various applications, including genetic testing, therapeutics, and research. Necessity arises from their role in facilitating the chemical synthesis of DNA and RNA, critical for the development of biopharmaceuticals and gene therapies. The end-use scope predominantly includes pharmaceuticals, biotechnology companies, and academic research institutions. Market insights reveal that the growing demand for personalized medicine and expanding applications in genomics and molecular diagnostics are the primary growth drivers. Furthermore, the increasing investment in synthetic biology research and technological advancements in gene editing technologies, such as CRISPR, present substantial opportunities. To leverage these developments, companies can focus on enhancing product purity, shelf-life, and cost-effectiveness of phosphoramidites.

KEY MARKET STATISTICS
Base Year [2023] USD 1.20 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 1.97 billion
CAGR (%) 7.29%

The market, however, faces challenges, primarily the high cost associated with phosphoramidite synthesis and the need for stringent storage conditions to maintain their reactivity. Regulatory hurdles and quality control issues also pose difficulties for market expansion. Moreover, the rapidly evolving nature of nucleic acid therapeutics demands continuous innovation, requiring significant investment in R&D. Areas ripe for innovation include the development of environmentally friendly synthesis methods and automated manufacturing processes to increase scalability and reduce costs. Exploring synthetic routes for producing more efficient and stable phosphoramidite analogs could also be beneficial.

For businesses aiming for growth, understanding the technicalities of the synthesis process and regulatory landscape is key. Establishing collaborations with research institutions and biotech firms to foster advancements in oligonucleotide therapeutics can offer competitive advantages. The dynamic market nature, characterized by rapid technological shifts and evolving application landscapes, underscores the importance of agility and adaptation. Recognizing these factors and strategically investing in technological advancements could position firms to successfully capitalize on emerging opportunities, despite existing market limitations and challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Phosphoramidite Market

The Phosphoramidite Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for DNA and RNA oligonucleotides in research and therapeutic applications
    • Surging demand for personalized medicine solutions utilizing oligonucleotide synthesis
    • Expansion of the pharmaceutical and biotechnology industries
  • Market Restraints
    • High cost and scalability issues with phosphoramidite synthesis
  • Market Opportunities
    • Surge in government funding in biotechnology research
    • Ongoing collaborations and partnerships within biotech and pharmaceutical companies
  • Market Challenges
    • Environmental and safety concerns associated with phosphoramidite synthesis

Porter's Five Forces: A Strategic Tool for Navigating the Phosphoramidite Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Phosphoramidite Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Phosphoramidite Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Phosphoramidite Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Phosphoramidite Market

A detailed market share analysis in the Phosphoramidite Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Phosphoramidite Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Phosphoramidite Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Phosphoramidite Market

A strategic analysis of the Phosphoramidite Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Phosphoramidite Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Actylis, Amadis Chemical Company Limited, American International Chemical, LLC by LeBaronBrown Industries LLC, Beijing SBS Genetech Co., Ltd., Bioneer Corporation, Biosynth Ltd., BOCSCI Inc., ChemGenes Corporation, Creative Biolabs, Inc., Hongene Biotech Corporation, Integrated DNA Technologies, Inc. by Danaher Corporation, LGC Genomics Limited, Lumiprobe Corporation, Maravai LifeSciences Holdings, Inc.,, MedChemExpress, Merck KGaA, PolyOrg, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., Twist Bioscience Corporation, and Wuhu Huaren Science and Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Phosphoramidite Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites, and Speciality Phosphoramidites.
  • Based on Purity Level, market is studied across High Purity and Standard Purity.
  • Based on End-User, market is studied across Academic & Research Institutions, Contract Research Organizations, Diagnostic Laboratories, and Pharmaceutical & Biotechnology.
  • Based on Application, market is studied across Diagnostics Development and Drug Discovery & Development.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for DNA and RNA oligonucleotides in research and therapeutic applications
      • 5.1.1.2. Surging demand for personalized medicine solutions utilizing oligonucleotide synthesis
      • 5.1.1.3. Expansion of the pharmaceutical and biotechnology industries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and scalability issues with phosphoramidite synthesis
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in government funding in biotechnology research
      • 5.1.3.2. Ongoing collaborations and partnerships within biotech and pharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental and safety concerns associated with phosphoramidite synthesis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Phosphoramidite Market, by Type

  • 6.1. Introduction
  • 6.2. DNA Phosphoramidites
  • 6.3. Dye-Labeled Phosphoramidites
  • 6.4. RNA Phosphoramidites
  • 6.5. Speciality Phosphoramidites

7. Phosphoramidite Market, by Purity Level

  • 7.1. Introduction
  • 7.2. High Purity
  • 7.3. Standard Purity

8. Phosphoramidite Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Contract Research Organizations
  • 8.4. Diagnostic Laboratories
  • 8.5. Pharmaceutical & Biotechnology

9. Phosphoramidite Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostics Development
  • 9.3. Drug Discovery & Development

10. Americas Phosphoramidite Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Phosphoramidite Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Phosphoramidite Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Codexis innovates with enzymatic RNA synthesis to enhance efficiency and scalability
    • 13.3.2. Innovassynth and Actylis partner to address Nucleic Acid supply chain vulnerabilities
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Thermo Fisher Scientific Inc.

Companies Mentioned

  • 1. AAT Bioquest, Inc.
  • 2. Actylis
  • 3. Amadis Chemical Company Limited
  • 4. American International Chemical, LLC by LeBaronBrown Industries LLC
  • 5. Beijing SBS Genetech Co., Ltd.
  • 6. Bioneer Corporation
  • 7. Biosynth Ltd.
  • 8. BOCSCI Inc.
  • 9. ChemGenes Corporation
  • 10. Creative Biolabs, Inc.
  • 11. Hongene Biotech Corporation
  • 12. Integrated DNA Technologies, Inc. by Danaher Corporation
  • 13. LGC Genomics Limited
  • 14. Lumiprobe Corporation
  • 15. Maravai LifeSciences Holdings, Inc.,
  • 16. MedChemExpress
  • 17. Merck KGaA
  • 18. PolyOrg, Inc.
  • 19. QIAGEN N.V.
  • 20. Thermo Fisher Scientific Inc.
  • 21. Tokyo Chemical Industry Co., Ltd.
  • 22. Twist Bioscience Corporation
  • 23. Wuhu Huaren Science and Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PHOSPHORAMIDITE MARKET RESEARCH PROCESS
  • FIGURE 2. PHOSPHORAMIDITE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHOSPHORAMIDITE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHOSPHORAMIDITE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DYE-LABELED PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY RNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY SPECIALITY PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY HIGH PURITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY STANDARD PURITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DIAGNOSTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023